Fundraising Fox

Eric Easom

Founder

Co-Founder, President & CEO at AN2 Therapeutics

Menlo Park, California, United States

FoundedAN2 Therapeutics

About

Eric Easom is CEO and Co-Founder of AN2 Therapeutics, a biotechnology company focused on infectious diseases. He also serves as a Board Member of the Drugs for Neglected Diseases initiative (DNDi).

Co-Founder, President & CEO at AN2 Therapeutics

Intro paths

→

In turn, Eric can intro founders to AN2 Therapeutics's investors below.

AN2 Therapeutics's investors · 6

Adjuvant CapitalNew York · $10M – $25M checksBioRock VenturesSan FranciscoFlucas VenturesJupiter · $100K – $5M checksHatteras Venture PartnersResearch Triangle · $500K – $4M checksMountain Group CapitalNashvilleRA CapitalBoston

Co-founders at AN2 Therapeutics

JS
Joseph S. ZakrzewskiCo-Founder & Director
GH
George H. TalbotCo-Founder & Senior Clinical Advisor
MR
Michael R.K. (Dickon) AlleyCo-Founder, SVP Research Fellow, Head of Biology

Experience

  1. Drugs for Neglected Diseases initiative (DNDi)Board Membercurrent2026 — presentGeneva, Switzerland
  2. AN2 Therapeutics, Inc.CEO & Co-Foundercurrent2017 — presentMenlo Park, CA
  3. Resilient Biotics, Inc.Director, Board of Directorscurrent2019 — presentDurham, NC
  4. Chagas Disease FoundationMember Board Of Directorscurrent2018 — presentAthens, GA USA
  5. Anacor PharmaceuticalsVice President, Neglected Diseases2009 — 2017Palo Alto, CA
  6. Infectious Disease Research InstituteMember Board of Directors2007 — 2014Greater Seattle Area
  7. Infectious Disease Research InstituteChair Board of Directors2010 — 2013Seattle, WA
  8. InteKrin Therapeutics, Inc.Sr. Director, Business Development and Marketing2007 — 2009
  9. MedImmuneDirector of Marketing2006 — 2007
  10. McKesson Medical SurgicalDirector, Pharmaceutical Division2005 — 2006
  11. Hope PharmaceuicalsFounder and CEO2003 — 2005
  12. Eli Lilly & Co.US Brand Manager, Endcrine Business Unit and Humatrope1990 — 2003
  13. Eli Lilly & Co.Corporate Business Development1997 — 2000
  14. Eli Lilly & Co.Finance1995 — 1997
  15. Eli Lilly & Co.Engineer, Manufacturing1990 — 1994

Skills & more

Infectious Disease R&D1Biotech R&D Leadership2Non-Dilutive FundraisingBiotechnology37Biochemistry5Business Development20Biotech BOD

From Eric's professional profile.

Frequently asked questions

Who is Eric Easom?
Eric Easom is CEO and Co-Founder of AN2 Therapeutics, a biotechnology company focused on infectious diseases. He also serves as a Board Member of the Drugs for Neglected Diseases initiative (DNDi).
Where does Eric Easom work?
Eric Easom is Co-Founder, President & CEO of AN2 Therapeutics.
What companies did Eric Easom found?
Eric Easom founded AN2 Therapeutics.
Where did Eric Easom go to school?
Eric Easom studied at Indiana University - Kelley School of Business (MBA, Marketing and Finance); University of Louisville (Masters, Electrical Engineering); University of Louisville (BS, Electrical Engineering).

Same school

Also attended Indiana University - Kelley School of Business96

Scott D. DorseyInvestor at High AlphaJoe HaraVice President at Marlin Equity PartnersJesseSaaS Growth Lead at Saas Ventures, L.L.C.Doug SillsPartner at Anthem Venture Management, LlcDanisha PasayaAnalyst, M&A Advisory at eGateway CapitalAaron DonenbergPortfolio Finance Associate at Energize Ventures

+ 90 more

Also attended University of Louisville12

Tomi AsantiManaging Partner, Real Estate at Innovestor VenturesEmily SnyderPrincipal at Borealis VenturesMike BiddlePartner at Evok InnovationsBillie Jo NutterInvestor at HCAP PartnersMarjolaine MandagotImpact & ESG Manager at Oryx ImpactJoe CarlucciOperations Specialist at First Round Capital

+ 6 more

Shared employers

Also worked at AN2 Therapeutics, Inc.1

Kabeer AzizCo-Founder and Partner at Adjuvant Capital

Also worked at Anacor Pharmaceuticals2

Angie YouSenior Advisor at Frazier Life SciencesAnders HovePartner at ACORN BIOVENTURES

Also worked at MedImmune10

Damian Crowtherex-AstraZeneca at PICUS CAPITALArthur SuckowInvestor at 82VSAliya LakhanInvestor at SUPPLY CHANGE CAPITALEd MathersPartner at New Enterprise Associates (NEA)Jorge CondeGeneral Partner at Andreessen HorowitzKarolina ZapadkaSenior Investment Manager at Parkwalk Advisors

+ 4 more

Also worked at McKesson Medical Surgical27

Nancy BrownAdvisor at Oncology VenturesJason ShookChief Operating Officer at Oncology VenturesDiana VerrilliGeneral Manager, Navista (a Cardinal Health company) at Oncology VenturesKendra PerlitzChief Operating Officer at Playground GlobalChing-Ping LinPartner & COO at Orbit StartupsJennifer CarterPartner & VP Venture Operations at McKesson Ventures

+ 21 more